NCT03364725View on ClinicalTrials.gov

Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

March 1, 2019

Conditions
Hepatitis CAddict Heroin
Interventions
DRUG

Glecaprevir-pibrentasvir

Glecaprevir-pibrentasvir will be dispensed to 30 patients recently detoxed off heroin in an acute detox center.

Trial Locations (1)

08844

ID CARE, Hillsborough

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Id Care

OTHER